Skip to main content
logo
Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.780
-0.050 (-2.73%)
Sep 28, 2026, 7:14 AM EDT - Market open

Alzamend Neuro Ratios and Metrics

Millions USD. Fiscal year is May - Apr.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Market Capitalization
94455395
Market Cap Growth
14.95%-0.56%-10.66%-90.80%-44.08%-
Enterprise Value
12154683
Last Close Price
1.831.145.9463.99738.851377.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
PB Ratio
1.525.921.10-1.8817.427.11
P/TBV Ratio
1.525.921.10-17.427.11

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Debt / Equity Ratio
----0.12--
Net Debt / Equity Ratio
-1.31-0.97-0.990.03-1.69-1.05
Net Debt / EBITDA Ratio
0.850.080.890.010.351.14
Net Debt / FCF Ratio
1.110.090.570.010.582.09
Quick Ratio
2.770.536.220.121.7912.07
Current Ratio
3.011.316.580.142.0312.37
Return on Equity (ROE)
-163.23%-373.18%-657.17%-4408.31%-181.47%-160.92%
Return on Assets (ROA)
-76.44%-163.99%-107.38%-189.73%-90.97%-88.35%
Return on Capital Employed (ROCE)
-156.70%-1195.70%-113.30%383.10%-488.30%-92.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Earnings Yield
-103.01%-202.25%-103.51%-203.75%-28.04%-13.03%
FCF Yield
-77.49%-186.01%-157.47%-172.40%-16.82%-7.08%
Buyback Yield / Dilution
-311.13%-640.27%-499.67%-4.07%-9.45%-22.64%
SEC Filings: 10-K · 10-Q